Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark D Gorrell

Showing results (11-20 of 99) with videos related to

Pageof 10
Sort By:
Molecular Cancer Research : MCR|September 17, 2013
Advances in understanding the expression and function of dipeptidyl peptidase 8 and 9Hui Zhang, Yiqian Chen, Fiona M Keane, et al.
Advances in Experimental Medicine and Biology|May 17, 2006
Dipeptidyl peptidase 8 has post-proline dipeptidyl aminopeptidase and prolyl endopeptidase activitiesJoohong Park, Katerina Ajami, Denise M T Yu, et al.
Clinical Science (London, England : 1979)|September 29, 2009
Inhibitor selectivity in the clinical application of dipeptidyl peptidase-4 inhibitionMark Kirby, Denise M T Yu, Steven O'Connor, et al.
Cancer Letters|April 6, 2016
Hepatocellular carcinoma: Mouse models and the potential roles of proteasesJames M Henderson, Hui Emma Zhang, Natasa Polak, et al.
Biochimica Et Biophysica Acta|July 13, 2004
Dipeptidyl peptidase 9 has two forms, a broad tissue distribution, cytoplasmic localization and DPIV-like peptidase activityKaterina Ajami, Catherine A Abbott, Geoffrey W McCaughan, et al.
Biological Chemistry|July 14, 2016
Dipeptidyl peptidase 9 substrates and their discovery: current progress and the application of mass spectrometry-based approachesClaire H Wilson, Hui Emma Zhang, Mark D Gorrell, et al.
Journal of Diabetes|May 13, 2020
COVID-19 and comorbidities: A role for dipeptidyl peptidase 4 (DPP4) in disease severity?Margaret F Bassendine, Simon H Bridge, Geoffrey W McCaughan, et al.
The FEBS Journal|February 15, 2011
Neuropeptide Y, B-type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein-αFiona M Keane, Naveed A Nadvi, Tsun-Wen Yao, et al.
Plos One|February 4, 2017
Fibroblast activation protein is dispensable in the anti-influenza immune response in miceSioh-Yang Tan, Sumaiya Chowdhury, Natasa Polak, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 14, 2010
The challenge of developing novel pharmacological therapies for non-alcoholic steatohepatitisDetlef Schuppan, Mark D Gorrell, Thomas Klein, et al.
Pageof 10

Showing results (11-20 of 99) with videos related to

Sort By:
Pageof 10
Molecular Cancer Research : MCR|September 17, 2013
Advances in understanding the expression and function of dipeptidyl peptidase 8 and 9Hui Zhang, Yiqian Chen, Fiona M Keane, et al.
Advances in Experimental Medicine and Biology|May 17, 2006
Dipeptidyl peptidase 8 has post-proline dipeptidyl aminopeptidase and prolyl endopeptidase activitiesJoohong Park, Katerina Ajami, Denise M T Yu, et al.
Clinical Science (London, England : 1979)|September 29, 2009
Inhibitor selectivity in the clinical application of dipeptidyl peptidase-4 inhibitionMark Kirby, Denise M T Yu, Steven O'Connor, et al.
Cancer Letters|April 6, 2016
Hepatocellular carcinoma: Mouse models and the potential roles of proteasesJames M Henderson, Hui Emma Zhang, Natasa Polak, et al.
Biochimica Et Biophysica Acta|July 13, 2004
Dipeptidyl peptidase 9 has two forms, a broad tissue distribution, cytoplasmic localization and DPIV-like peptidase activityKaterina Ajami, Catherine A Abbott, Geoffrey W McCaughan, et al.
Biological Chemistry|July 14, 2016
Dipeptidyl peptidase 9 substrates and their discovery: current progress and the application of mass spectrometry-based approachesClaire H Wilson, Hui Emma Zhang, Mark D Gorrell, et al.
Journal of Diabetes|May 13, 2020
COVID-19 and comorbidities: A role for dipeptidyl peptidase 4 (DPP4) in disease severity?Margaret F Bassendine, Simon H Bridge, Geoffrey W McCaughan, et al.
The FEBS Journal|February 15, 2011
Neuropeptide Y, B-type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein-αFiona M Keane, Naveed A Nadvi, Tsun-Wen Yao, et al.
Plos One|February 4, 2017
Fibroblast activation protein is dispensable in the anti-influenza immune response in miceSioh-Yang Tan, Sumaiya Chowdhury, Natasa Polak, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 14, 2010
The challenge of developing novel pharmacological therapies for non-alcoholic steatohepatitisDetlef Schuppan, Mark D Gorrell, Thomas Klein, et al.
Pageof 10